Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim announced today collaboration with Yale University, New Haven, Connecticut, USA, with the goal of researching novel therapeutic targets in the field of immune-modulation. Immune-modulation refers to a range of treatments aimed at harnessing a patient’s immune system to fight disease.

Help employers find you! Check out all the jobs and post your resume.